Pharmacological treatments for adults with overweight and obesity without diabetes-Reference-Cited by-同舟云学术

Pharmacological treatments for adults with overweight and obesity without diabetes

Published:2024-04-18 Issue:4 Volume:2024 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Shang Wenru¹²,Hui Xu¹²,Li Meixuan¹²,Ren Junjie¹²,Huang Xinyu¹²,Li Jing¹²³,Wang Xiaoqin⁴,Wang Qi⁵,Ma Yanfang⁶,Madrid Eva⁷⁸,Bracchiglione Javier⁸⁹¹⁰,Jiang Lei¹¹,Yang Kehu¹²,Yao Liang⁵

Affiliation:

1. Evidence-Based Medicine Center, School of Basic Medical Sciences; Lanzhou University; Lanzhou China

2. Evidence-Based Social Science Research Center, School of Public Health; Lanzhou University; Lanzhou China

3. The Second Affiliated Hospital of Xi'an Jiaotong University; Xi'an China

4. The Michael G. DeGroote Institute for Pain Research and Care; McMaster University; Hamilton Canada

5. Department of Health Research Methods, Evidence, and Impact; McMaster University; Hamilton Canada

6. School of Chinese Medicine; Hong Kong Baptist University; Hong Kong Special Administrative Region China

7. Interdisciplinary Centre for Health Studies CIESAL, Universidad de Valparaíso; Viña del Mar Chile

8. Cochrane Associate Centre, School of Medicine; Universidad de Valparaíso; Viña del Mar Chile

9. Interdisciplinary Centre for Health Studies CIESAL; Universidad de Valparaíso; Viña del Mar Chile

10. Iberoamerican Cochrane Centre; Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), CIBERESP; Barcelona Spain

11. Sixth Department of General Surgery, The First Hospital; Lanzhou University; Lanzhou China

Publisher

Wiley

Reference135 articles.

1. Efficacy and safety of glucagon-like peptide-1/glucagon receptor co-agonist JNJ-64565111 in individuals with obesity without type 2 diabetes mellitus: a randomized dose-ranging study;Alba;Clinical Obesity,2021

2. Interaction revisited: the difference between two estimates;Altman;BMJ,2003

3. High blood pressure: ACC/AHA releases updated guideline;Armstrong;American Family Physician,2018

4. Efficacy of an orlistat-resveratrol combination for weight loss in subjects with obesity: a randomized controlled trial;Arzola-Paniagua;Obesity,2016

5. Clinical pharmacology and mechanism of action of zonisamide;Biton;Clinical Neuropharmacology,2007